Cara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Cash & Equivalents	52.18	64.15	13.45	32.09	18.71	15.85	10.16	13.56	15.8	53.36	Upgrade
Short-Term Investments	48.98	81.66	153.58	149.24	136.7	146.3	83.18	46.18	91.64	0	Upgrade
Cash & Cash Equivalents	101.17	145.81	167.04	181.33	155.41	162.15	93.34	59.75	107.44	53.36	Upgrade
Cash Growth	-30.62%	-12.71%	-7.88%	16.68%	-4.16%	73.73%	56.23%	-44.39%	101.34%	308.69%	Upgrade
Receivables	3.32	3.76	0.46	0.56	0.97	0.93	0.12	0.09	0.08	0	Upgrade
Inventory	2.82	2.38	2.58	0	0	0	0	0	0	0	Upgrade
Other Current Assets	8.85	16.96	3.22	13.18	9.27	5.06	1.6	1.61	1.41	-0.21	Upgrade
Total Current Assets	116.16	168.91	173.29	195.07	165.66	168.14	95.06	61.45	108.93	53.15	Upgrade
Property, Plant & Equipment	8.19	1.98	3.6	5.12	3.74	0.88	1.18	1.61	1.26	2.08	Upgrade
Long-Term Investments	1.5	11.35	70.16	70.57	63.16	21.4	0	0	0	0	Upgrade
Other Long-Term Assets	0	0	0	0.41	0.41	0.41	0.77	0.77	0.7	0.7	Upgrade
Total Long-Term Assets	9.69	13.33	73.77	76.09	67.3	22.68	1.95	2.38	1.96	2.78	Upgrade
Total Assets	125.84	182.24	247.06	271.16	232.96	190.82	97	63.83	110.9	55.93	Upgrade
Accounts Payable	25.59	21.54	15.86	16.88	19.67	13.62	8.51	11.53	5.27	1.95	Upgrade
Deferred Revenue	0	0	0	0	22.26	42.01	0	0	0	1.45	Upgrade
Current Debt	0	1.92	1.76	1.6	0.97	0	0	0	0	0	Upgrade
Other Current Liabilities	0	0	0	0	0	-15.18	0	0	0	0	Upgrade
Total Current Liabilities	25.59	23.46	17.62	18.48	42.89	40.45	8.51	11.53	5.27	3.4	Upgrade
Long-Term Debt	43.17	0	1.92	3.67	3.35	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	0	0	0	0	16.75	1.72	1.57	0.59	0.87	Upgrade
Total Long-Term Liabilities	43.17	0	1.92	3.67	3.35	16.75	1.72	1.57	0.59	0.87	Upgrade
Total Liabilities	68.76	23.46	19.53	22.16	46.25	57.19	10.22	13.1	5.85	4.27	Upgrade
Total Debt	43.17	1.92	3.67	5.28	4.32	0	0	0	0	0	Upgrade
Debt Growth	2150.63%	-47.78%	-30.37%	22.13%	-	-	-	-	-	-	Upgrade
Retained Earnings	-684.75	-566.23	-480.76	-392.32	-400.73	-294.35	-220.34	-162.17	-104.89	-80.2	Upgrade
Comprehensive Income	-0.26	-1.67	-0.36	0.07	0.17	-0.11	-0.07	0	-0.04	0	Upgrade
Shareholders' Equity	57.09	158.78	227.52	249	186.71	133.63	86.78	50.73	105.04	51.66	Upgrade
Net Cash / Debt	58	143.89	163.36	176.06	151.1	162.15	93.34	59.75	107.44	53.36	Upgrade
Net Cash / Debt Growth	-59.69%	-11.92%	-7.21%	16.52%	-6.82%	73.73%	56.23%	-44.39%	101.34%	308.69%	Upgrade
Net Cash Per Share	1.07	2.68	3.22	3.67	3.54	4.52	2.99	2.19	4.36	2.55	Upgrade
Working Capital	90.57	145.45	155.67	176.58	122.76	127.69	86.55	49.91	103.67	49.75	Upgrade
Book Value Per Share	1.05	2.96	4.49	5.25	4.38	3.72	2.78	1.86	4.27	2.46	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).